leisure time -WSS

leisure time

author：knowledge 2025-09-06 04:13:07 - browse：513

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： What we need to know about Arena Bioworks

knowledge

WSS

HCA sued by state AG for quality issues at Mission Health

The real point of Kenneth Smith’s execution by nitrogen gas

HCA sued by state AG for quality issues at Mission Health

FDA drug safety: Singulair case shows systemic surveillance flaws

Can sheer will power keep patients alive in their dying hours?

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

focus

leisure time

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Apple Vision Pro: A first look at health apps on the new VR headset

23andMe had bad news about my health. I wish a person had delivered it

Drinking less cuts risk of oral cavity, esophageal cancer: Report

In age of alternative facts, a scholarly course on calling out crap

Biden administration opens offers in Medicare drug price negotiations

Anesthesiologist group: stop taking Ozempic before surgery

Some dementia cases could be undiagnosed liver disease

The high cost of giving birth even with insurance

Do digital therapeutics have a future in medicine?

hotspot

Why health care costs have stayed mostly flat since 2010

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Congressmen charge Covid hearing ‘could have been an email’

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Christmas in the PICU brings some surprising joy

Grail spinoff by Illumina should end disastrous merger attempt

focus

knowledge

knowledge

Wikipedia